David Price - Progetto LIBRA

More documents

Recommendations

Info

Thomas M, von Ziegenweidt J, Lee AJ, <strong>Price</strong> D. High-dose inhaled corticosteroids versus add-on long-acting beta -agonists in asthma: An observational study. J Allergy Clin Immunol 2009;123:116-21 Exacerbations reduced by increased antiinflammatory therapy Increasing ICS associated with lower rates of exacerbations
Overall Asthma Control achieving Current Control reducing Future Risk defined by defined by Symptoms Reliever use Instability/ worsening Exacerbations Activity Lung function Lung function loss Medication adverse effects GINA 2006; NIH/NAEPP Expert Report No.3 2007; ATS/ERS Task Force on Asthma Severity & Control, ERJ 2008
Page 1: David Price GPIAG Professor of Prim
Page 4 and 5: Aberdeen because of the “Silver D
Page 8: Rhinitis Allergic • Intermittent
Page 12 and 13: Gendo, K. et. al. Ann Intern Med 20
Page 14 and 15: If disease persistent or not respon
Page 17 and 18: ARIA Classification Intermittent .
Page 19 and 20: Assessment: Royal College of Physic
Page 24 and 25: Sneezing 72% Runny nose 66% Intermi
Page 26 and 27: Q14. During a week when you experie
Page 29 and 30: 81% of asthma patients report rhini
Page 31: Thomas M, von Ziegenweidt J, Lee AJ
Page 36 and 37: p
Page 38 and 39: Variable OR 95% CI p Rhinitis Compa
Page 40: Symptom severity Impact On health
Page 44: No. GPs (n=188) 0 50 100 150 200 Na
Page 47: www.asthmatrak.org www.theipcrg.org
Page 50: Rhinitis frequently under‐diagnos

David Price - Progetto LIBRA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?